Narat Srivali: New Systematic Review and Meta-Analysis on Glucocorticoid Therapy and The Risk of VTE
Narat Srivali, Assistant Professor at Duke University Medical Center, shared on LinkedIn about a recent article he and Federica De Giacomi co-authored, published in Expert Opinion on Pharmacotherapy, adding:
”Excited to share our new systematic review and meta-analysis on glucocorticoid therapy and the risk of venous thromboembolism (VTE).
We found that glucocorticoid use is associated with an approximately 2.6-fold increased risk of VTE, with the highest risk seen early in treatment, at higher doses, and with systemic formulations.
These findings may help clinicians think more carefully about VTE risk stratification when initiating glucocorticoids, especially in patients with additional risk factors.”
Title: Glucocorticoid therapy and risk of venous thromboembolism: a systematic review and meta-analysis with exploration of dose, duration, and route-specific effects
Authors: Narat Srivali, Federica De Giacomi
Stay updated on all scientific advances with Hemostasis Today.
-
May 22, 2026, 10:23Rucha Patil: Insights from The National Haemophilia Conclave 2026
-
May 22, 2026, 10:02Greta Mulders: Nursing Leadership in Haemophilia Gene Therapy
-
May 22, 2026, 08:45Dirk Sibbing: Ethnicity and Antiplatelet Therapy Outcomes in CCS
-
May 22, 2026, 08:35Jason Brandon: On Lyophilized Hemostatic Supplementation at Simmons Research Day 2026
-
May 22, 2026, 08:28Inconsistent D-Dimer Assay Reporting in VTE Studies – JTH
-
May 22, 2026, 08:21Vincent Jongkind: We Invite You to Participate in a Delphi Study for a Core Outcome Set in Acute Limb Ischemia
-
May 22, 2026, 07:46Jae Hyun Byun: Spatial Transcriptomics and the Emerging Complexity of Plaque Vulnerability
-
May 22, 2026, 07:45Thom Lysen: Tracking TTS Risk After COVID-19 Viral Vector-Based Vaccines
-
May 22, 2026, 07:44WFH Celebrates Landmark Progress at the 79th World Health Assembly